Listen to this page using ReadSpeaker

William T. Schmidt

William T. Schmidt was named Chief Executive Officer (CEO) of The Foundation Fighting Blindness, Inc. (FFB) in May, 2005. As CEO, Schmidt is responsible for the overall management of the Foundation, which is the largest non-governmental source of funding for retinal degenerative disease research in the world. He also serves as CEO of the FFB Clinical Research Institute, the clinical research arm of FFB. Schmidt has had extensive experience as a senior executive for a number of high-profile and respected health research advocacy organizations, including the Juvenile Diabetes Research Foundation International (JDRF). As Vice President of Public Affairs at JDRF, he directed the government relations, communications, media relations and foundation relations departments. During that time, Mr. Schmidt spearheaded a successful effort to increase Type 1 diabetes federal research programs by $240 million in new and dedicated funding over a three-year period. An honors graduate of Amherst College, Mr. Schmidt also received his J.D. from the DePaul University College of Law and completed the Kellogg Graduate School of Management’s Executive Development Program. The urgent mission of The Foundation Fighting Blindness, Inc. (FFB) is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa (RP), macular degeneration, Usher Syndrome, and the entire spectrum of retinal degenerative diseases.

The following articles were authored by William T. Schmidt

Celebrating ‘Momentum’: FFB’s 2013 Annual Report

The home page for "Momentum," FFB's 2013 annual reportWhen the words “annual report” are mentioned, visions of charts, graphs and numbers usually pop into one’s head. While the Foundation’s 2013 annual report includes numbers, it mostly features examples of the report’s theme, “Momentum,” a word that aptly describes our progress in the fight against vision-robbing retinal diseases. With that in mind, I invite you to check out the online version of the report.
Continue Reading…

The Challenge

A Series on How People Affected by Retinal Diseases Adjust to Continual Vision Loss

Eye on the Cure x Dress-Lace Inc Mini Skater Lace Dress

Eye on the Cure x Dress-Lace Inc Mini Skater Lace Dress – Coral / Long Sleeves

Wear this Eye on the Cure x exclusive mini skater lace dress when you want to draw lots of positive attention to yourself. It is expertly crafted from high quality fabric with close attention to all of the details that make this one of our most popular skater dresses. Choose your favorite color between coral and mint green. The dress features a rounded neckline with a vee shaped cutout at the front and center. The bodice is unembellished and cut into a regular configuration that is true to size. The dress has long sleeves. There is a wide, matching band at the waistline. The skirt portion of this dress is cut into a perfect circle and has a moderate amount of fullness for a short, flirty look. It is machine washable in warm water and may be tumbled dry on a low temperature setting. The hemline is mini length, ending at the upper thigh area of the leg. This lace dress is available for purchase in sizes Small, Medium, Large and Extra-Large.

Banding Together for Vision Research

National Alliance for Eye and Vision ResearchThere’s no denying that collaboration is key to every aspect of the Foundation’s work – whether it’s researchers sharing their findings among peers to advance treatments, volunteers banding together to fundraise for events or venture capitalists investing  in start-up companies developing vision-saving treatments. And my new role, as board secretary for the National Alliance for Eye and Vision Research, or NAEVR, is no exception.

Continue Reading…

Top 12 Research Advancements of 2012

Image of lab beakerAt the Foundation Fighting Blindness, we are always looking forward. Our scientists are continually focused on achieving the next sight-saving breakthrough, and our donors and volunteers are always looking for new opportunities to raise more money to drive the research.

But for a moment, as we put the wraps on 2012, it is very inspiring to look back on the past year and reflect on the many exciting advancements that have been made in our quest for treatments and cures.
Continue Reading…

Please Join Us in the “Save Research” Campaign

Save Blindness ResearchWith the elections now behind us, the U.S. Congress needs to address an issue that could delay by years, perhaps even decades, the ability of those with serious diseases to access treatments that will at the very least change their lives for the better, if not save them. The looming “fiscal cliff” – Congress’ current means of tackling a substantial budget deficit – is a combination of tax increases and spending cuts that will kick in January 1, 2013, if no further legislative action is taken. And it’s a huge mistake.
Continue Reading…